Navigation Links
MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
Date:6/16/2009

Phase 3 PROTEGE ENCORE Clinical Trial Initiated

ROCKVILLE, Md. and INDIANAPOLIS, June 16 /PRNewswire/ -- MacroGenics, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the PROTEGE trial achieved its targeted patient enrollment. The trial is a pivotal Phase 2/3 clinical study evaluating teplizumab, an investigational compound under development for the treatment of individuals with recent-onset type 1 diabetes.

The PROTEGE trial is a randomized, double-blind, multi-center, multi-national, 4-arm, controlled study designed to evaluate the safety and efficacy of teplizumab in individuals with recent-onset type 1 diabetes, aged 8 to 35, who are within 12 weeks of their diagnosis. More than 530 individuals are enrolled in the study across 14 countries, including the United States. The primary composite endpoint for PROTEGE includes both the patient's total daily insulin usage and his/her HbA1c levels at 12 months. Secondary endpoints are evaluated at 24 months. Longer term safety and efficacy data from patients who complete the PROTEGE trial are being collected in a separate Phase 3 study called the PROTEGE Extension trial.

"The completion of enrollment of the PROTEGE study is an important milestone for MacroGenics and for the type 1 diabetes research community," stated Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. "We appreciate the dedication of the patients, their caregivers and clinical investigators who helped advance this important late-stage clinical trial."

The companies also announced today that they have initiated the PROTEGE ENCORE trial, another Phase 3 global study of teplizumab in individuals with recent-onset type 1 diabetes, designed to capture patient-reported outcome measures in addition to safety and efficacy data. Information about the PROTEGE and PROTE
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
3. Study Showed Lillys GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
4. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
5. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
6. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
7. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
8. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
9. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
10. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
11. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014 Adaptive ... Next Generation Sequencing to profile the adaptive immune ... Scientific Advisory Board to provide strategic and clinical ... suite of assays in the diagnosis and monitoring ... focus of the SAB will be to support ...
(Date:9/29/2014)... BOSTON , Sept. 29, 2014  Arisaph ... on discovery and development of novel therapies for ... has been awarded a phase II Small Business ... I grant, both from the National Cancer Institute ... II award of $1,066,916 supports research and development ...
(Date:9/29/2014)... TEL-AVIV, Israel , Sept. 29, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... medication for the treatment of liver diseases and ... EndoPAT™ devices and accessories from Itamar Medical Ltd. ... company whose technology has been cleared by the ...
Breaking Medicine Technology:Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 2Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 4Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3
... Hospira, Inc. (NYSE: HSP ... announced positive results from a Phase I U.S. clinical ... renal (kidney) dysfunction who have anemia. Hospira,s trial met ... and distribution in the body, for Hospira,s EPO and ...
... 6, 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the Rodman ... 2011 at 2:25pm ET at the Waldorf Astoria Hotel ... Pharmaceuticals, Inc. Founded in 2008, Omthera ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
(Date:9/29/2014)... Garden City, NY (PRWEB) September 30, 2014 ... , R.N., B.S.N., Clinical Manager Specialist, as a 2014 ... with this prestigious distinction for leadership in clinical care. ... the country, spanning virtually every industry and profession, the ... networking community with over 600,000 members and nearly 300 ...
(Date:9/29/2014)... Park Avenue Dental, a leading ... A. Sherman who has dedicated his career to providing ... announced its inclusion in the Patient Connect 365 dentist ... to private accounts so that they may manage online ... system also allows patients to request appointments, better communicate ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the ... and was worn by a man, Ötzi the Iceman. ... the direction of using small ornamental purses—which evolved into ... a leading online supplier of fashion accessories, has released ... are fashionable. , For most men, they do ...
(Date:9/29/2014)... Chicago, IL (PRWEB) September 29, 2014 ... the option to review life insurance quotes from top ... search tool available now presents price exploration options at ... quotations are now presented inside of the formatted consumer ... insurers. The life plans that are offered to review ...
(Date:9/29/2014)... Humility of Mary Health Partners will offer SlimDown, ... and Velma Davis Family YMCA in Boardman and St. Joe’s ... manage their weight by making lifestyle changes with regard to ... to 6:30 p.m. Wednesdays at the YMCA, 2045 McClurg Road, ... the Mall (next to the rear entrance to Sears) beginning ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Sarah Shiermeister, Clinical Manager Specialist at Gentiva Health Services, a 2014 Professional Woman of the Year 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 3Health News:Life Insurance Quotes for Chicago Residents Now Quoted Using New Agency Tool Online 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2
... those at risk, expert says, , FRIDAY, Aug. 14 (HealthDay ... bones in older men, says a new study. , The ... 65 and older who had their sex hormone levels measured ... with low levels of estradiol or high levels of sex ...
... , , TUSTIN, Calif., Aug. ... company with major operations in China, announced today it has filed ... Exchange Act of 1934, as amended, with the Securities and Exchange ... the second quarter ended June 30, 2009. This filing provides for ...
... , WESTON, Fla., Aug. 14 Kidz-Med, ... Sheets: ASFX), is announcing a change in the distribution channels of ... Recently, the Company has learned of Walgreens, intent to cut many ... including the Kidz-Med Thermofocus. To the Company,s knowledge, this decision is ...
... , , Additional 28 ... WASHINGTON, Aug. 14 Today, Secretary of Veterans Affairs Eric ... other assistance in 28 additional communities across the country where the ... , , "VA is committed to providing ...
... , , EDINA, Minn., Aug. 14 ... Assure blood glucose meter test strips do not use GDH-PQQ (glucose ... blood glucose results in patients who are using certain therapeutic products. ... of products use a glucose-specific enzyme and can, therefore, distinguish between ...
... , , WHITE PLAINS, N.Y., ... Next Generation Nutrition Grants, donating a total of $120,000 to four non-profit ... families. , , (Photo: http://www.newsc ... 7 67 ) , , Through ...
Cached Medicine News:Health News:Sex Hormone Levels Linked to Fractures in Men 2Health News:AMDL Inc. Files Notification of Late Filing for Form 10-Q 2Health News:Child Health and Safety Product Distribution Channel Changes 2Health News:Secretary Shinseki Announces Expansion of Counseling for Combat Veterans 2Health News:ARKRAY Statement Regarding U.S. Food and Drug Administration's Public Health Notification: Potentially Fatal Errors With GDH-PQQ Glucose Monitoring Technology 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 3Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 4Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 5Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 6Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 7
... FH system uses a ... infrastructure operating in ... communication of patient information. ... of up to 640 ...
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: